Abbott Laboratories (ABT) Income from Discontinued Operations (2012 - 2020)

Abbott Laboratories has disclosed Income from Discontinued Operations across 8 years of filings, most recently posting $4.0 million for Q4 2020.

• In Q4 2020, Income from Discontinued Operations changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2020 stood at $24.0 million (changed N/A YoY), while the FY2020 annual figure was $24.0 million, changed N/A from the prior year.
• Income from Discontinued Operations came in at $4.0 million for Q4 2020 at Abbott Laboratories, down from $20.0 million in the prior quarter.
• In the past five years, Income from Discontinued Operations ranged from a high of $260.0 million in Q1 2016 to a low of -$1.0 million in Q4 2018.
• Average Income from Discontinued Operations over 4 years is $37.1 million, with a median of $18.0 million recorded in 2016.
• Year-over-year, Income from Discontinued Operations soared 900.0% in 2016 and sank 102.78% in 2018.
• Over 4 years, Income from Discontinued Operations stood at $33.0 million in 2016, then climbed by 9.09% to $36.0 million in 2017, then slumped by 102.78% to -$1.0 million in 2018, then jumped by 500.0% to $4.0 million in 2020.
• Per Business Quant data, the three most recent Income from Discontinued Operations figures were $4.0 million in Q4 2020, $20.0 million in Q1 2020, and -$1.0 million in Q4 2018.